dPCRとqPCRの市場規模および予測（2020年～2030年）、世界および地域別シェア、動向、成長機会分析：処理別（定量PCR（qPCR）、デジタルPCR（dPCR））、製品別（試薬・消耗品、機器、ソフトウェア・サービス）、用途別（研究用途、臨床用途、エンドユーザー（病院・診断センター、製薬・バイオテクノロジー企業、研究所・学術機関、法医学研究所、臨床研究機関）、地域別（北米、欧州、アジア太平洋、中東・アフリカ、中南米）

dPCR and qPCR Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment [Quantitative PCR (qPCR) and Digital PCR (dPCR)], Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

dPCRとqPCRの市場規模は、2022年の89億7,600万米ドルから2030年には182億3,000万米ドルに成長すると予想され、2022年から2030年のCAGRは9.3%を記録すると推定される。 dPCRとqPCR市場の成長は、遺伝病と感染症... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年11月8日	US$4,550 シングルユーザライセンスライセンス・価格情報注文方法はこちら	159	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

dPCRとqPCRの市場規模は、2022年の89億7,600万米ドルから2030年には182億3,000万米ドルに成長すると予想され、2022年から2030年のCAGRは9.3%を記録すると推定される。

dPCRとqPCR市場の成長は、遺伝病と感染症の発生率の増加、遺伝子合成への投資と資金の増加、PCR技術の技術的進歩に起因している。

近年、PCRのような分子手法は診断技術として発展してきた。この方法は医療従事者が幅広い感染症を正確に診断することを可能にし、不可欠な研究・診断ツールと考えられている。PCR法は1本のDNAから数百万コピーのDNAを作り出すことができる。また、病気の早期診断が可能であるため、病気のコントロールに不可欠な役割を果たしている。PCRは異なる検査室間で比較可能な再現性のある結果をもたらし、それゆえ世界中で受け入れられている。PCR技術は新興国でも広く受け入れられ、利用されている。世界保健機関（WHO）の「発展途上国におけるPCR検査施設の設立に関する報告書2016」によると、WHOはWHO東南アジア諸国の全11加盟国にPCR検査施設を設立するために必要な技術支援を行っている。検査室は質の高い医療を提供するのに役立つだろう。これらのPCR検査室は、逆転写酵素PCR（RT-PCR）、マルチプレックスPCR、リアルタイムPCR、In-situ PCR、デジタルPCR（dPCR）など、必要に応じてさまざまなPCR技術を採用している。簡便、迅速、特異性の高い病気のスクリーニングや、臨床微生物学、ウイルス学、寄生虫学、バイオテクノロジー、および関連分野での応用の増加により、発展途上国におけるdPCRおよびqPCR市場は予測期間中に有利な機会を経験すると予想される。

液滴デジタルPCR（ddPCR）は、デジタルPCRを実行するための新しい技術です。水-油エマルジョン液滴技術を利用します。検査サンプルは約20,000の液滴に分画され、各液滴で標的DNA鎖の増幅が行われる。その後、ddPCRは個々の液滴中の核酸ターゲットをデジタル測定する。したがって、この技術は標的DNA分子の高精度で絶対的な定量を可能にし、診断や研究への幅広い応用を可能にする。qPCRでは、DNA定量はサイクル閾値（CT）から得られる。外部キャリブレーターが必要であり、不完全な増幅は絶対定量に影響する。Droplet Digital PCR (ddPCR)は検量線なしでターゲットDNAを直接カウントする。従って、ddPCRの出現により、科学者は複雑な遺伝的ランドスケープを探索し、新たな疾患との関連を発見・検証し、分子診断学の新時代を定義することができるようになる。従って、ddPCRの開発は、将来dPCRおよびqPCR市場の大きなトレンドになるだろう。

アプリケーションベースの洞察

アプリケーションに基づき、dPCRおよびqPCR市場は研究アプリケーション、臨床アプリケーション、法医学アプリケーションに区分される。2022年には、臨床アプリケーション分野が市場で最大のシェアを占め、2022～2030年に最も高いCAGRを記録すると予測されています。分子生物学技術は疾病診断に革命をもたらし、今や検査室診断の重要な一部となっている。dPCRとqPCR技術は現在、糖尿病、感染症、癌、その他を含む多くの疾患の診断に使用されている。例えば、消化器感染症、院内感染症（HAI）、呼吸器感染症、性感染症などの診断には、リアルタイムPCR技術のリダジェネキットが開発されている。これらの分子的手法は早期、高感度、特異的な診断を可能にするため、臨床応用分野は予測期間中に成長が見込まれている。

リアルタイムPCR技術は、遺伝子の変異を検出するために使用されており、がんの診断に役立っている。dPCRはまた、喀痰、尿、脳脊髄液、血漿などの無細胞DNA（cfDNA）サンプル中の腫瘍マーカーの正確な検出を可能にする。例えば、dPCRは上皮成長因子受容体（EGFR）、KRAS、ESR1の変異を検出するのに一般的に用いられている。

さらに、技術の進歩により、がんの診断や治療のための分子マーカーが提供されつつある。2023年4月、サーモフィッシャーサイエンティフィックはQuantStudio Dxシリーズ用のCE-IVDマークを取得した37種類のリアルタイムPCRアッセイキットを発表した。

エンドユーザーベースの洞察

dPCRおよびqPCR市場は、エンドユーザーに基づき、病院・診断センター、製薬・バイオテクノロジー企業、研究所・学術機関、法医学研究所、臨床研究機関に区分される。2022年には、病院と診断センターセグメントが市場で最大のシェアを占め、2022-2030年に最も高いCAGRを記録すると予測されている。

dPCRおよびqPCR市場では、病院と診断センターが大きな市場シェアを占めている。dPCRとqPCRは、細菌、ウイルス、真菌を含む病原体の早期かつ正確な検出を可能にし、高い感度と特異性などの利点を提供する。

さらに、病院は急性および慢性疾患の治療のために患者に高度な診断と治療の選択肢を提供し、病院や診断センターは医療施設に専門的な科学機器を提供するため、PCR技術の採用率ははるかに高くなっています。さらに、新興国における医療インフラの継続的な拡大、感染症の発生率の高さ、入院患者数の増加が、迅速かつ高感度な診断ツールに対するニーズを生み出している。さらに、早期かつ効率的な疾病診断と治療に対する需要の高まり、診断用途のdPCR製品の上市数の増加、疾病診断においてdPCRが提供する利点（他のPCR技術と比較して）、臨床診断と疾病診断の両技術が提供する利点に関連する一般市民の意識の高まりが、市場成長の燃料となっています。

さらに、診断検査室にはハイテク機器が充実しており、検査する様々なサンプルのワークフローや管理が容易になっている。例えば、サーモフィッシャーサイエンティフィック社は、QuantStudio 5、QuantStudio 6 Flex、QuantStudio 7、QuantStudio 12k、QuantStudio 3D、QuantStudio Absolute Q AutoRun dPCR Suiteなど、複数のPCRのバリエーションを提供している。同様に、Bio-Rad Laboratories, Inc.、Fluidigm Corporation、Eppendorf、Agilent Technologies, Inc.のような数社が、病院や診断センターの能力や要求に応じてPCR装置を提供している。

米国疾病予防管理センター（Centers for Disease Control and Prevention）、医学研究未来基金（Medical Research Future Fund）、世界保健機関（WHO）などは、dPCRおよびqPCR市場レポート作成時に参照した一次および二次情報源のひとつである。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. dPCR and qPCR Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. dPCR and qPCR Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Genetic and Infectious Diseases
5.1.2 Rising Investments and Funds for Gene Synthesis
5.1.3 Technological Advancements in PCR Technologies
5.2 Market Restraints
5.2.1 High Costs of PCR Systems
5.2.2 Technical Limitations Associated with qPCR
5.3 Market Opportunities
5.3.1 Growing Adoption of PCR Methods in Emerging Countries
5.4 Future Trends
5.4.1 Development of Droplet Digital PCR
5.5 Impact Analysis:
6. dPCR and qPCR Market - Global Market Analysis
6.1 dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
7. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Quantitative PCR
7.3.1 Overview
7.3.2 Quantitative PCR: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Digital PCR
7.4.1 Overview
7.4.2 Digital PCR: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by Product
8.1 Overview
8.2 dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
8.3 Reagents & Consumables
8.3.1 Overview
8.3.2 Reagents & Consumables: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Software & Services
8.5.1 Overview
8.5.2 Software & Services: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Research Application
9.3.1 Overview
9.3.2 Research Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Clinical Application
9.4.1 Overview
9.4.2 Clinical Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 dPCR and qPCR Market, by Clinical Application, 2020–2030 (US$ Million)
9.5 Forensic Application
9.5.1 Overview
9.5.2 Forensic Application: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10. Global dPCR and qPCR Market – Revenue and Forecast to 2030 – by End-User
10.1 Overview
10.2 dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
10.3 Hospitals and Diagnostic Centers
10.3.1 Overview
10.3.2 Hospitals and Diagnostic Centers: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical and Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research Laboratories and Academic Institutes
10.5.1 Overview
10.5.2 Research Laboratories and Academic Institutes: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Forensic Laboratories
10.6.1 Overview
10.6.2 Forensic Laboratories: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.7 Clinical Research Organizations
10.7.1 Overview
10.7.2 Clinical Research Organizations: dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
11. dPCR and qPCR Market - Geographical Analysis
11.1 North America dPCR and qPCR Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.4 North America: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.5 North America: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.5.1 North America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.1.6 North America: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.1.6.1 North America dPCR and qPCR Market, by Country
11.1.6.2 US
11.1.6.2.1 US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.2.2 US: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.6.2.3 US: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.6.2.4 US: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.6.2.4.1 US: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.1.6.2.5 US: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.1.6.3 Canada
11.1.6.3.1 Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.3.2 Canada: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.6.3.3 Canada: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.6.3.4 Canada: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.6.3.4.1 Canada: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.1.6.3.5 Canada: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.1.6.4 Mexico
11.1.6.4.1 Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.6.4.2 Mexico: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.1.6.4.3 Mexico: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.1.6.4.4 Mexico: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.1.6.4.4.1 Mexico: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.1.6.4.5 Mexico: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2 Europe dPCR and qPCR Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.4 Europe: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.5 Europe: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.5.1 Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6 Europe: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.1 Europe dPCR and qPCR Market, by Country
11.2.6.2 UK
11.2.6.2.1 UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.2.2 UK: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.2.3 UK: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.2.4 UK: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.2.4.1 UK: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.2.5 UK: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.3 Germany
11.2.6.3.1 Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.3.2 Germany: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.3.3 Germany: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.3.4 Germany: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.3.4.1 Germany: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.3.5 Germany: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.4 France
11.2.6.4.1 France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.4.2 France: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.4.3 France: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.4.4 France: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.4.4.1 France: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.4.5 France: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.5 Italy
11.2.6.5.1 Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.5.2 Italy: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.5.3 Italy: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.5.4 Italy: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.5.4.1 Italy: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.5.5 Italy: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.6 Spain
11.2.6.6.1 Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.6.2 Spain: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.6.3 Spain: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.6.4 Spain: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.6.4.1 Spain: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.6.5 Spain: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.2.6.7 Rest of Europe
11.2.6.7.1 Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.2.6.7.2 Rest of Europe: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.2.6.7.3 Rest of Europe: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.2.6.7.4 Rest of Europe: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.2.6.7.4.1 Rest of Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.2.6.7.5 Rest of Europe: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3 Asia Pacific dPCR and qPCR Market, Revenue and Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.5.1 Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6 Asia Pacific: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.1 Asia Pacific dPCR and qPCR Market, by Country
11.3.6.2 China
11.3.6.2.1 China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.2.2 China: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.2.3 China: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.2.4 China: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.2.4.1 China: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.2.5 China: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.3 Japan
11.3.6.3.1 Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.3.2 Japan: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.3.3 Japan: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.3.4 Japan: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.3.4.1 Japan: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.3.5 Japan: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.4 India
11.3.6.4.1 India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.4.2 India: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.4.3 India: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.4.4 India: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.4.4.1 India: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.4.5 India: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.5 Australia
11.3.6.5.1 Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.5.2 Australia: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.5.3 Australia: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.5.4 Australia: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.5.4.1 Australia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.5.5 Australia: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.6 South Korea
11.3.6.6.1 South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.6.2 South Korea: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.6.3 South Korea: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.6.4 South Korea: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.6.4.1 South Korea: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.6.5 South Korea: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.3.6.7 Rest of Asia Pacific
11.3.6.7.1 Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.3.6.7.2 Rest of Asia Pacific: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.3.6.7.3 Rest of Asia Pacific: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.3.6.7.4 Rest of Asia Pacific: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.3.6.7.4.1 Rest of Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.3.6.7.5 Rest of Asia Pacific: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4 Middle East & Africa dPCR and qPCR Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.5.1 Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.4.6 Middle East & Africa: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.1 Middle East & Africa dPCR and qPCR Market, by Country
11.4.6.2 Saudi Arabia
11.4.6.2.1 Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.2.2 Saudi Arabia: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.2.3 Saudi Arabia: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.2.4 Saudi Arabia: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.2.4.1 Saudi Arabia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.4.6.2.5 Saudi Arabia: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.3 UAE
11.4.6.3.1 UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.3.2 UAE: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.3.3 UAE: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.3.4 UAE: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.3.4.1 UAE: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.4.6.3.5 UAE: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.4 South Africa
11.4.6.4.1 South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.4.2 South Africa: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.4.3 South Africa: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.4.4 South Africa: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.4.4.1 South Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.4.6.4.5 South Africa: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.4.6.5 Rest of Middle East & Africa
11.4.6.5.1 Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.4.6.5.2 Rest of Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.4.6.5.3 Rest of Middle East & Africa: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.4.6.5.4 Rest of Middle East & Africa: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.4.6.5.4.1 Rest of Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.4.6.5.5 Rest of Middle East & Africa: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5 South & Central America dPCR and qPCR Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.4 South & Central America: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.5 South & Central America: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.5.1 South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.5.6 South & Central America: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5.6.1 South & Central America dPCR and qPCR Market, by Country
11.5.6.2 Brazil
11.5.6.2.1 Brazil dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.2.2 Brazil: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.6.2.3 Brazil: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.6.2.4 Brazil: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.6.2.4.1 Brazil: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.5.6.2.5 Brazil: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5.6.3 Argentina
11.5.6.3.1 Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.3.2 Argentina: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.6.3.3 Argentina: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.6.3.4 Argentina: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.6.3.4.1 Argentina: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.5.6.3.5 Argentina: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
11.5.6.4 Rest of South & Central America
11.5.6.4.1 Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.5.6.4.2 Rest of South & Central America: dPCR and qPCR Market, by Treatment, 2020–2030 (US$ Million)
11.5.6.4.3 Rest of South & Central America: dPCR and qPCR Market, by Product, 2020–2030 (US$ Million)
11.5.6.4.4 Rest of South & Central America: dPCR and qPCR Market, by Application, 2020–2030 (US$ Million)
11.5.6.4.4.1 Rest of South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
11.5.6.4.5 Rest of South & Central America: dPCR and qPCR Market, by End-User, 2020–2030 (US$ Million)
12. dPCR and qPCR Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in dPCR and qPCR Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takara Bio Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Qiagen NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Standard BioTools Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Lepu Medical Technology Beijing Co Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 F. Hoffmann-La Roche Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bio-Rad Laboratories Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Agilent Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Genome Diagnostics Pvt Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 SWOT Analysis
13.10.5 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The dPCR and qPCR market size is expected to grow from US$ 8.976 billion in 2022 to US$ 18.230 billion by 2030; it is estimated to record a CAGR of 9.3% during 2022-2030.

The dPCR and qPCR market growth is attributed to the increasing incidence of genetic and infectious diseases, rising investments and funds for gene synthesis, and technological advancements in PCR technologies.

In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. According to the World Health Organization Report on the Establishment of PCR Laboratory in Developing Countries 2016, WHO is providing necessary technical assistance to establish PCR laboratories in all 11 member states of the WHO South East Asia countries. The laboratories will help in providing high-quality medical care. These PCR laboratories have adopted different PCR technologies such as Reverse transcriptase PCR (RT-PCR), Multiplex PCR, Real-time PCR, In-situ PCR, Digital PCR (dPCR), and others depending on their need. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.

Droplet Digital PCR (ddPCR) is a new technique for performing digital PCR. It utilizes water-oil emulsion droplet technology. A sample to be tested is fractionated into around 20,000 droplets, and then amplification of the target DNA strand is carried out in each droplet. The ddPCR then digitally measures the nucleic acid targets in the individual droplet. Thus, the technique gives high precision and absolute quantification of target DNA molecules and enables wide application in diagnosis and research. In qPCR, DNA quantification is obtained from the cycle threshold (CT). External calibrators are required, and imperfect amplification affects absolute quantitation. Droplet Digital PCR (ddPCR) directly counts the target DNA without the calibration curve. Thus, with the advent of ddPCR, scientists will be able to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics. Thus, the development of ddPCR would become a major trend in the dPCR and qPCR market in the future.

Application-Based Insights

Based on application, the dPCR and qPCR market is segmented into research application, clinical application, and forensic application. In 2022, the clinical application segment held the largest share of the market and is anticipated to register the highest CAGR during 2022–2030. Molecular biology techniques have revolutionized disease diagnosis and are now a crucial part of laboratory diagnostics. The dPCR and qPCR techniques are now being used in the diagnosis of many diseases, including diabetes, infectious diseases, cancer, and others. For instance, real-time PCR technology RIDA GENE kits are developed for the diagnosis of gastrointestinal infections, hospital-acquired infections (HAI), respiratory infections, sexually transmitted infections, and other parameters. As these molecular methods allow early, sensitive, and specific diagnosis, the clinical application segment is expected to witness growth over the forecast period.

Real-time PCR technologies have been used to detect mutation in genes, which helps in the diagnosis of cancer. dPCR also enables precise detection of tumor markers in cell-free DNA (cfDNA) samples like sputum, urine, cerebrospinal fluid, plasma, and others. dPCR is more effective in detecting single-nucleotide polymorphism among the wild-type sequences. For example, dPCR is commonly used to detect mutation in epidermal growth factor receptor (EGFR), KRAS, and ESR1.

Furthermore, technological advancements are offering molecular markers for diagnosing and treating cancer. In April 2023, Thermo Fisher Scientific introduced 37 CE-IVD-marked real-time PCR assay kits for its QuantStudio Dx series of instruments to detect numerous infectious diseases.

End User-Based Insights

Based on end user, the dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. In 2022, the hospitals and diagnostic centers segment held the largest share of the market and is anticipated to register the highest CAGR during 2022–2030.

Hospitals and diagnostic centers contribute a significant market share to the dPCR and qPCR market. Hospitals are the primary centers for a patient seeking highly advanced treatment under the guidance of much-trained personnel. dPCR and qPCR offer advantages such as high sensitivity and specificity, allowing early and accurate detection of pathogens, including bacteria, viruses, and fungi.

In addition, hospitals offer advanced diagnosis and treatment options for patients to treat acute and chronic conditions, and the adoption of PCR techniques is much higher in hospitals and diagnostic centers as they provide healthcare facilities with specialized scientific equipment. Moreover, the continued expansion of healthcare infrastructure across emerging countries, the high incidences of infectious diseases, and the growing number of hospital admissions has created a need for rapid and sensitive diagnostic tools. Additionally, growing demand for early and efficient disease diagnosis and treatment, the increasing number of dPCR product launches for diagnostic applications, the advantages offered by dPCR in disease diagnosis (as compared to other PCR technologies), and growing awareness among public associated with the benefits offered by both these technologies for clinical and disease diagnosis fuel the market growth.

Furthermore, diagnostic laboratories are well-equipped with hi-tech equipment that enables easy workflow and management of various samples to be tested. For instance, Thermo Fisher Scientific, Inc. offers multiple variants of its PCR, including QuantStudio 5, QuantStudio 6 Flex, QuantStudio 7, QuantStudio 12k, QuantStudio 3D, and QuantStudio Absolute Q AutoRun dPCR Suite. Similarly, several companies, such as Bio-Rad Laboratories, Inc., Fluidigm Corporation, Eppendorf, and Agilent Technologies, Inc., offer PCR devices to hospitals and diagnostic centers based on their capacity and requirements.

Centers for Disease Control and Prevention, Medical Research Future Fund, and the World Health Organization (WHO) are among the primary and secondary sources referred to while preparing the dPCR and qPCR market report.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（america europe）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（america europe）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?